(Press-News.org) PHILADELPHIA - Mounting evidence demonstrates that the pathological proteins linked to the onset and progression of neurodegenerative disorders are capable of spreading from cell-to-cell within the brains of affected individuals and thereby "spread" disease from one interconnected brain region to another. A new study found no evidence to support concerns that these abnormal disease proteins are "infectious" or transmitted from animals to humans or from one person to another. The study by researchers from the Perelman School of Medicine at the University of Pennsylvania, in conjunction with experts from the U.S. Centers for Disease Control and the Department of Health and Human Services, appears online in JAMA Neurology.
Cell-to-cell transmission is a potentially common pathway for disease spreading and progression in diseases like Alzheimer's (AD) and Parkinson's (PD) disease as well as frontotemporal lobar degeneration (FTLD), amyotrophic lateral sclerosis (ALS) and other related disorders. It appears that misfolded proteins spread from one cell to another and that the affected neurons become dysfunctional, while these toxic proteins go on to damage other regions of the brain over time.
"By interrogating an existing database with information on a cohort of well-characterized patients, we were able to determine that there is no evidence suggesting the pathology of Alzheimer's or Parkinson's can transmit between humans," said senior author John Q. Trojanowski, MD, PhD, professor of Pathology and Laboratory Medicine and co-director of the Penn Center for Neurodegenerative Disease Research. "We can now redouble efforts to find treatments, via immunotherapies or other approaches to stop the spreading of these toxic proteins between cells."
In order to verify whether such proteins could potentially be carried from person to person, the team of researchers analyzed data from an existing cohort of patients who had received human growth hormone (hGH) from cadaveric pituitary glands via a national program, as a beneficial treatment for stunted growth, before synthetic hGH was available. Nearly 7,700 patients were treated with cadaver-derived hGH (c-hGH) in the US between 1963 and 1985. In the mid-1980s, more than 200 patients worldwide who had received c-hGH inadvertently contaminated with prion proteins from affected donor pituitary tissue went on to develop an acquired form of Creutzfeldt-Jakob disease (CJD), a rare, degenerative, invariably fatal brain disorder caused by pathological prion proteins that also are the cause of Mad Cow disease. Since then, the cohort has been followed to track any additional cases of CJD, with extensive medical histories for patients over the 30+ years since the c-hGH therapy was stopped after the link to CJD was discovered in 1985.
In this current study, researchers looked for signs of an elevated risk of AD, PD, FTLD or ALS among this group and found that none of the c-hGH recipients developed AD, PD or FTLD. The team did identify three ALS cases of unclear significance, given that no traces of ALS disease proteins (TDP-43, FUS and Ubiquilin) were found in human pituitary glands, despite the presence of pathological AD (tau, Aβ) and PD (alpha-synuclein) proteins. This clarified that c-hGH recipients were most likely exposed to these neurodegenerative disease proteins linked to AD, PD and FTLD but this did not result in transmission of disease from person to person.
"This cohort is an invaluable resource and should continue to be followed, especially as we rapidly increase our understanding of disease progression in neurodegenerative conditions," said David Irwin, MD, lead author, and fellow in the Center for Neurodegenerative Disease Research and the department of Neurology in the Perelman School of Medicine.
###The other co-authors of this study are Joseph Y. Abrams, Lawrence B. Schonberger, Ellen W. Leschek, James L. Mills, and Virginia M.-Y. Lee. This research was supported by grants from the National Institute on Aging (P30 AG010124, Alzheimer's Core Center grant, T32-AG000255), Intramural Research Program and National Institute of Child Health and Development at the National Institutes of Health.
Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.
The Perelman School of Medicine is currently ranked #2 in U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $479.3 million awarded in the 2011 fiscal year.
The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; and Pennsylvania Hospital – the nation's first hospital, founded in 1751. Penn Medicine also includes additional patient care facilities and services throughout the Philadelphia region.
Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2011, Penn Medicine provided $854 million to benefit our community.
Penn study confirms no transmission of Alzheimer's proteins between humans
2013-02-05
ELSE PRESS RELEASES FROM THIS DATE:
Scientists turn toxic by-product into biofuel booster
2013-02-05
UPTON, NY-Scientists studying an enzyme that naturally produces alkanes -- long carbon-chain molecules that could be a direct replacement for the hydrocarbons in gasoline -- have figured out why the natural reaction typically stops after three to five cycles. Armed with that knowledge, they've devised a strategy to keep the reaction going. The biochemical details -- worked out at the U.S. Department of Energy's Brookhaven National Laboratory and described in the Proceedings of the National Academy of Sciences the week of February 4, 2013 -- renew interest in using the enzyme ...
Paired genes in stem cells shed new light on gene organization and regulation
2013-02-05
CAMBRIDGE, Mass. (February 4, 2013) – Whitehead Institute researchers have determined that DNA transcription, the process that produces messenger RNA (mRNA) templates used in protein production, also runs in the opposite direction along the DNA to create corresponding long noncoding RNAs (lncRNAs). Moreover, the mRNAs and lncRNAs are transcribed coordinately as stem cells differentiate into other cell types. This surprising finding could redefine our understanding of gene organization and its regulation.
"It's a surprise to me that genes come in pairs," says Whitehead ...
TV viewing, exercise habits may significantly affect sperm count
2013-02-05
Boston, MA — Men's sperm quality may be significantly affected by their levels of physical activity, according to a new study led by researchers at Harvard School of Public Health (HSPH). They found that healthy young men who were sedentary, as measured by hours of TV viewing, had lower sperm counts than those who were the most physically active.
"We know very little about how lifestyle may impact semen quality and male fertility in general so identifying two potentially modifiable factors that appear to have such a big impact on sperm counts is truly exciting," said ...
A 'nudge' can be the ethical choice
2013-02-05
HOUSTON -- (Feb. 6, 2013) – As patients and physicians share decision-making in choices among treatment options, decision aids such as videos, websites, pamphlets or books are coming to play an important role. However, in some cases, it may be ethical for the decision aids to provide a "nudge" toward a particular option, said researchers from Baylor College of Medicine, the Michael E. DeBakey Veterans Affairs Medical Center and the University of Texas MD Anderson Cancer Center in a report that appears in the journal Health Affairs.
In general, decision aids are meant ...
Study highlights important role that patients play in determining outcomes
2013-02-05
EUGENE, Ore. — When it comes to health care, patients with the motivation, knowledge, skills and confidence to manage their own health have better health outcomes and incur fewer health care costs.
Those are the findings of a study led by Judith Hibbard, a professor emerita in the Department of Planning, Public Policy and Management at the University of Oregon. Hibbard and co-authors found that patients with the lowest level of "activation"— that is, those most lacking in the skills and confidence to be actively engaged in their health care — had average costs that were ...
Damaged blood vessels loaded with amyloid worsen cognitive impairment in Alzheimer's disease
2013-02-05
NEW YORK (February 4, 2013) -- A team of researchers at Weill Cornell Medical College has discovered that amyloid peptides are harmful to the blood vessels that supply the brain with blood in Alzheimer's disease -- thus accelerating cognitive decline by limiting oxygen-rich blood and nutrients. In their animal studies, the investigators reveal how amyloid-β accumulates in blood vessels and how such accumulation and damage might be ultimately prevented.
Their study, published in the Feb. 4 online edition of the Proceedings of the National Academy of Sciences (PNAS), ...
Researchers develop Rx for deafness, impaired balance in mouse model of Usher syndrome
2013-02-05
New Orleans, LA – Jennifer Lentz, PhD, Assistant Professor of Otorhinolaryngology & Biocommunications and a member of the Neuroscience Center of Excellence at LSU Health Sciences Center New Orleans, is the lead author of a paper reporting that hearing and balance can be rescued by a new therapy in a mouse model of Usher syndrome (Usher) that contains the mutation responsible for type 1C Usher. The results provide the first evidence that congenital deafness can be effectively overcome by treatment early in development to correct gene expression. The paper, Rescue of hearing ...
Monogamous birds read partner's food desires
2013-02-05
New research shows that male Eurasian Jays in committed relationships are able to share food with their female partner according to her current desire.
The behaviour suggests the potential for 'state-attribution' in these birds – the ability to recognise and understand the internal life and psychological states of others.
The research was carried out in Professor Nicola Clayton's Comparative Cognition lab at Cambridge University's Department of Psychology, and is published today in the journal PNAS.
Researchers tested mated jays and separated males from females. ...
Birds may need a hand to weather climate change
2013-02-05
A new study led by Durham University and BirdLife International, shows that many bird species are likely to suffer under future climate change, and will require enhanced protection of important sites, better management of the wider countryside, and in some of the most extreme cases may need to be physically moved to climatically suitable areas to help them survive.
The priority, the researchers say, is for stronger protection and effective management of networks of important sites for conservation which currently support priority species and could offer new habitat for ...
Research suggests meerkat predator-scanning behaviour is altruistic
2013-02-05
VIDEO:
In order to spot potential predators, adult meerkats often climb to a higher vantage point or stand on their hind legs. If a predator is detected, they use several different...
Click here for more information.
In order to spot potential predators, adult meerkats often climb to a higher vantage point or stand on their hind legs. If a predator is detected, they use several different alarm calls to warn the rest of the group. New Cambridge research shows that they are ...